Axsome Therapeutics, Inc. is a high-risk pharmaceutical company based in the United States. Specializing in central nervous system (CNS) disorders, Axsome is dedicated to developing innovative therapies for conditions with limited treatment options. With a focus on ESG practices, Axsome's pipeline of products includes AXS-05, AXS-07, AXS-12, and AXS-14. Operating as a single segment, Axsome is committed to sustainable and efficient healthcare solutions.